The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
A prospective study of obesity and cancer risk (Sweden)
Abstract
Objective [corrected] We evaluated the relation between obesity and the risks for various forms of cancer.Methods In a population-based cohort of 28,129 hospital patients (8165 men, 19,964 women) with any discharge diagnosis of obesity (9557 only diagnosis, 5266 primary, 13,306 secondary) during 1965-1993, cancer incidence was ascertained through 1993 by record linkage to the nationwide Swedish Cancer Registry. Cancer risk was estimated using the standardized incidence ratio (SIR, with 95% confidence interval), which is the ratio of the observed number of cancers to that expected.Results Overall, a 33% excess incidence of cancer was seen in obese persons, 25% in men and 37% in women. Significant risk elevations were observed for cancers of the small intestine (SIR = 2.8; 95% CI 1.6-4.5), colon (1.3; 1.1-1.5), gallbladder (1.6; 1.1-2.3), pancreas (1.5; 1.1-1.9), larynx (2.1; 1.1-3.5), renal parenchyma (2.3; 1.8-2.8), bladder (1.2; 1.0-1.6), cervix uteri (1.4; 1.1-1.9), endometrium (2.9; 2.5-3.4), ovary (1.2; 1.1-1.5), brain (1.5; 1.2-1.9), and connective tissue (1.9; 1.1-3.0), and for lymphomas (1.4; 1.0-1.7), with higher risk observed for Hodgkin's disease only in men (3.3; 1.4-6.5) and for non-Hodgkin's lymphoma only in women (1.6; 1.2-2.1). The association of obesity with risk of breast, prostate and pancreas cancers was modified by age.Conclusions Obesity is associated with more forms of cancer than previously reported.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“whilst both older males and females are at increased risk of hepatobiliary (gallbladder and pancreatic), and genitourinary (renal, bladder, uterine, cervical and prostate) cancers [33].”
From Obesity pharmacotherapy in older adults: a narrative review of evidence (2025) · cites this paper as [33]
Citations
Cites
Overweight and obesity in the United States: prevalence and trends, 1960–1994
Flegal, K., Carroll, M., Kuczmarski, R., & Johnson, C. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800541 · Cited by 3,045
Energy and protein requirements*
Pacey, A., & Payne, P. (2019) · Routledge eBooks · doi:10.4324/9780429036279-4 · Cited by 2,545
Body Weight and Mortality among Women
Manson, J. E., Willett, W. C., Stampfer, M. J., Colditz, G. A., Hunter, D. J., Hankinson, S. E., Hennekens, C. H., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509143331101 · Cited by 2,005
Limitations of the Application of Fourfold Table Analysis to Hospital Data
Berkson, J. (1946) · Biometrics Bulletin · doi:10.2307/3002000 · Cited by 1,810 · cited 1×
“Another concern in linked-registry studies is the possibility of confounding by associated conditions such as alcoholism, diabetes or other unmeasured factors in a cohort of hospitalized subjects [42].”
BackgroundA Prospective Study of Obesity and Risk of Coronary Heart Disease in Women
Manson, J. E., Colditz, G. A., Stampfer, M. J., Willett, W. C., ROSNER, B. A., Monson, R. R., Speizer, F. E., & Hennekens, C. H. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003293221303 · Cited by 1,403
The design and analysis of cohort studies
Breslow, N. E., & Day, N. E. (1987) · International Agency for Research on Cancer eBooks · Cited by 1,312
Variations in mortality by weight among 750,000 men and women
Lew, E. A., & Garfinkel, L. (1979) · Journal of Chronic Diseases · doi:10.1016/0021-9681(79)90119-x · Cited by 1,169
Weight, Weight Change, and Coronary Heart Disease in Women: Risk Within the 'Normal' Weight Range
Willett, W. C. (1995) · JAMA · doi:10.1001/jama.1995.03520300035033 · Cited by 924
Increased cell division as a cause of human cancer.
Preston‐Martin, S., Pike, M. C., Ross, R. K., Jones, P. A., & Henderson, B. E. (1990) · PubMed · Cited by 896
Colorectal Cancer: Molecules and Populations
Potter, J. D. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.11.916 · Cited by 876
Flagged first, then by citations
Research works printed but not linked: 6
- Mattson B, Wallgren A (1984) Completeness of the Swedish Cancer Registry. Acta Radiol 23: 305-313.
- The Cancer Registry (1995) Cancer Incidence in Sweden 1980 (and 1993) (annual publications). Stockholm: National Board of Health and Welfare.
- Fraumeni JF Jr, Devesa SS, McLaughlin JF, Stanford JL (1996) Biliary tract cancer. In: Schottenfield D, Fraumeni JJF, eds. Cancer Epidemiology and Prevention. Oxford: Oxford University Press, pp. 794-805.
- Ji BT, Hatch MC, Chow WH, et al. (1996) Anthropometric and reproductive factors and the risk of pancreatic cancer: a case-control study in Shanghai, China. Int J Cancer 66: 32-37.
- Flyvbjerg A, Orskov H (1990) Growth hormone, insulin-like growth factors and diabetes. In: Alberti KGMM, Krall LP, eds, The Diabetes Annual 5. Amsterdam: Elsevier, pp. 642-656.
- Hotzel D (1986) Suboptimal nutritional status in obesity. Bibl Nutr Dieta 37: 36-41.
Cited by
Sorted by citations
Items 101–200 of 584
Lacey, J. V., Swanson, C. A., Brinton, L. A., Altekruse, S. F., Barnes, W. A., Gravitt, P. E., Greenberg, M., Hadjimichael, O. C., McGowan, L., Mortel, R., et al. (2003) · Cancer · doi:10.1002/cncr.11567 · Cited by 130
Epidemiology of Cancers of the Small Intestine: Trends, Risk Factors, and Prevention
Barsouk, A. A., Rawla, P., Barsouk, A., & Thandra, K. C. (2019) · Medical Sciences · doi:10.3390/medsci7030046 · Cited by 128
Hepatocellular carcinoma and lifestyles
Saran, U., Humar, B., Kolly, P., & Dufour, J. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.08.028 · Cited by 126
Adiponectin: a link between obesity and cancer
Barb, D., Pazaitou‐Panayiotou, K., & Mantzoros, C. S. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.8.917 · Cited by 125
Stolzenberg‐Solomon, R. Z., Adams, K., Leitzmann, M., Schairer, C., Michaud, D. S., Hollenbeck, A. R., Schatzkin, A. G., & Silverman, D. T. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm361 · Cited by 125
Anderson, K. E., Mack, T. M., & Silverman, D. T. (2006) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195149616.003.0038 · Cited by 124
Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection
Hung, C. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i18.2265 · Cited by 124
Stolzenberg‐Solomon, R. Z., Pietinen, P., Taylor, P. R., Virtamo, J. R. K., & Albanes, D. (2002) · Cancer Causes & Control · doi:10.1023/a:1015729615148 · Cited by 124
Energy Balance, Physical Activity, and Cancer Risk
Fair, A. M., & Montgomery, K. M. (2008) · Methods in molecular biology · doi:10.1007/978-1-60327-492-0_3 · Cited by 124
Rabinovitch, R. A., Grant, B. L., Berkey, B. A., Raben, D., Ang, K. K., Fu, K. K., Cooper, J. S., & for the Radiation Therapy Oncology Group (2005) · Head & Neck · doi:10.1002/hed.20335 · Cited by 121
Hepatocellular carcinoma in Asia: Prevention strategy and planning
Ashtari, S. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i12.1708 · Cited by 121
Hepatocellular carcinoma in non‐alcoholic steatohepatitis: Growing evidence of an epidemic?
Hashimoto, E., & Tokushige, K. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00872.x · Cited by 120
Possible Genomic Imprinting of Three Human Obesity–Related Genetic Loci
Dong, C., Li, W., Geller, F., Lei, L., Li, D., Gorlova, O. Y., Hebebrand, J., Amos, C. I., Nicholls, R. D., & Price, R. A. (2005) · The American Journal of Human Genetics · doi:10.1086/428438 · Cited by 120
Body Mass Index, Physical Activity, and Bladder Cancer in a Large Prospective Study
Koebnick, C., Michaud, D. S., Moore, S. C., Park, Y., Hollenbeck, A. R., Ballard-Barbash, R. R., Schatzkin, A. G., & Leitzmann, M. F. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0026 · Cited by 119
Non‐Hodgkin lymphoma and obesity: A pooled analysis from the InterLymph Consortium
Willett, E. V., Morton, L. M., Hartge, P. A., Becker, N., Bernstein, L., Boffetta, P., Bracci, P. M., Cerhan, J. R., Chiu, B. C. ‐., Cocco, P., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.23344 · Cited by 118
Donato, F., Gelatti, U., Limina, R., & Fattovich, G. (2006) · Oncogene · doi:10.1038/sj.onc.1209557 · Cited by 117
Carcinoma hepatocelular: epidemiologia, biologia, diagnóstico e terapias
Gomes, M. A., Priolli, D. G., Tralhão, J. G., & Botelho, M. F. (2013) · Revista da Associação Médica Brasileira · doi:10.1016/j.ramb.2013.03.005 · Cited by 116
Jonsson, F., Wolk, A., Pedersen, N. L., Lichtenstein, P., Terry, P., Ahlbom, A., & Feychting, M. (2003) · International Journal of Cancer · doi:10.1002/ijc.11266 · Cited by 116
Self-citationLuo, J., Iwasaki, M., Inoue, M., Sasazuki, S., Otani, T., Ye, W., Tsugane, S., & for the JPHC Study Group (2007) · Cancer Causes & Control · doi:10.1007/s10552-007-9002-z · Cited by 115
SAUNDERS, D., SEIDEL, D., Allison, M., & Lyratzopoulos, G. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04271.x · Cited by 114
Excess body weight and obesity—the link with gastrointestinal and hepatobiliary cancer
Kant, P., & Hull, M. A. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.23 · Cited by 113
Alcohol, Smoking, and Body Size in Relation to Incident Hodgkin's and Non-Hodgkin's Lymphoma Risk
Lim, U., Morton, L. M., Subar, A. F., Baris, D., Stolzenberg‐Solomon, R. Z., Leitzmann, M. F., Kipnis, V., Mouw, T., Carroll, L., Schatzkin, A. G., et al. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm122 · Cited by 113
Lear, S. A., Toma, M., Birmingham, C. L., & Frohlich, J. J. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00196-3 · Cited by 114
Variants of the Adiponectin and Adiponectin Receptor 1 Genes and Breast Cancer Risk
Kaklamani, V., Sadim, M. S., Hsi, A., Offit, K., Oddoux, C., D, H. O. M., Ahsan, H., Pasche, B., & Mantzoros, C. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0533 · Cited by 112
Cerhan, J. R. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf082 · Cited by 110
Energy Intake, Physical Activity, Energy Balance, and Cancer: Epidemiologic Evidence
Pan, S. Y., & DesMeules, M. (2008) · Methods in molecular biology · doi:10.1007/978-1-60327-492-0_8 · Cited by 109
Anthropometric variables, physical activity, and incidence of ovarian cancer
ANDERSON, J. P., Ross, J. A., & Folsom, A. R. (2004) · Cancer · doi:10.1002/cncr.20146 · Cited by 104
Elfström, P., Granath, F. N., Ye, W., & Ludvigsson, J. F. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.06.029 · Cited by 103
Impact of Body Mass Index on Survival of Patients With Surgically Treated Renal Cell Carcinoma
Donat, S. M., Salzhauer, E. W., Mitra, N., Yanke, B. V., Snyder, M. E., & Russo, P. (2005) · The Journal of Urology · doi:10.1097/00005392-200601000-00013 · Cited by 102
van Dijk, B. A. C., Schouten, L. J., Kiemeney, L. A. L. M., Goldbohm, R. A., & van den Brandt, P. A. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh344 · Cited by 101
Aune, D., Navarro Rosenblatt, D. A., Chan, D. S. M., Abar, L., Vingeliene, S., Vieira, A. R., Greenwood, D. C., & Norat, T. (2015) · International Journal of Cancer · doi:10.1002/ijc.29207 · Cited by 100
Body size and ovarian cancer: case–control study and systematic review (Australia)
Purdie, D. M., Bain, C. J., Webb, P. M., Whiteman, D. C., Pirozzo, S., & Green, A. C. (2001) · Cancer Causes & Control · doi:10.1023/a:1012267619561 · Cited by 100
Some life-style factors and the risk of invasive epithelial ovarian cancer in Swedish women
Riman, T., Dickman, P. W., Nilsson, S., Nordlinder, H., Magnusson, C., & Persson, I. R. (2004) · European Journal of Epidemiology · doi:10.1007/s10654-004-1633-8 · Cited by 100
Schouten, L. J. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwf224 · Cited by 99
Cancer in Obese Women: Potential Protective Impact of Bariatric Surgery
McCawley, G. M., Ferriss, J. S., Geffel, D. L., Northup, C. J., & Modesitt, S. C. (2009) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2009.01.045 · Cited by 98
Kukla, M., Mazur, W., Bułdak, R. J., & Żwirska-Korczala, K. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00105 · Cited by 98
Kizer, N. T., Thaker, P. H., Gao, F., Zighelboim, I., Powell, M. A., Rader, J. S., Mutch, D. G., & Grigsby, P. W. (2010) · Cancer · doi:10.1002/cncr.25544 · Cited by 97
Bezemer, I. D., Rinaldi, S., Dossus, L., van Gils, C. H., Peeters, P. H. M., van Noord, P. A. H., Bueno-de-Mesquita, H. B., Johnsen, S. P., Overvad, K., Olsen, A., et al. (2005) · Cancer Causes & Control · doi:10.1007/s10552-004-7472-9 · Cited by 97
Overweight/obesity and cancer genesis: More than a biological link
Irigaray, P., Newby, J. A., Lacomme, S., & Belpomme, D. (2007) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2007.10.008 · Cited by 96
Body mass index and risk of multiple myeloma: A meta‐analysis
Larsson, S. C., & Wolk, A. (2007) · International Journal of Cancer · doi:10.1002/ijc.22968 · Cited by 96
Self-citationThe association between overweight, obesity and ovarian cancer: a meta-analysis
Liu, Z., Zhang, T., Zhao, J., Qi, S.-F., Du, P., Liu, D., & Tian, Q. (2015) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyv150 · Cited by 96
Leptin and Adiponectin: new players in the field of tumor cell and leukocyte migration
Lang, K., & Ratke, J. (2009) · Cell Communication and Signaling · doi:10.1186/1478-811x-7-27 · Cited by 95
Weight control and the management of obesity after menopause: the role of physical activity
Dubnov‐Raz, G., Brzezinski, A., & Berry, E. M. (2003) · Maturitas · doi:10.1016/s0378-5122(02)00328-6 · Cited by 94
Interacting Genetic Loci on Chromosomes 20 and 10 Influence Extreme Human Obesity
Dong, C., Wang, S., Li, W., Li, D., Zhao, H., & Price, R. A. (2003) · The American Journal of Human Genetics · doi:10.1086/345648 · Cited by 91
Hsing, A. W., Rashid, A., Devesa, S. S., & Fraumeni, J. F. (2006) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195149616.003.0040 · Cited by 91
Self-citationObesity and Risk for Brain/CNS Tumors, Gliomas and Meningiomas: A Meta-Analysis
Sergentanis, T. Ν., Tsivgoulis, G. K., Perlepe, C., Ntanasis‐Stathopoulos, I., Tzanninis, I., Sergentanis, I. N., & Ψαλτοπούλου, Θ. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136974 · Cited by 90
Nöthlings, U., Wilkens, L. R., Murphy, S. P., Hankin, J. H., Henderson, B. E., & Kolonel, L. N. (2007) · Cancer Causes & Control · doi:10.1007/s10552-006-0100-0 · Cited by 89
Engel, L. S., Laden, F., Andersen, A., Strickland, P. T., Blair, A. E., Needham, L. L., Barr, D. B., Wolff, M. S., Helzlsouer, K. J., Hunter, D. J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3906 · Cited by 88
Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
Massoud, O. I., & Charlton, M. (2017) · Clinics in Liver Disease · doi:10.1016/j.cld.2017.08.014 · Cited by 88
Engeland, A., Tretli, S., Hansen, S., & Bjørge, T. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj353 · Cited by 87
Obesity and thyroid cancer: epidemiologic associations and underlying mechanisms
Pazaitou‐Panayiotou, K., Pοlyzos, S. A., & Mantzoros, C. S. (2013) · Obesity Reviews · doi:10.1111/obr.12070 · Cited by 86
Anti-cancer role of SPARC, an inhibitor of adipogenesis
Nagaraju, G. P., & Sharma, D. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.12.001 · Cited by 86
Obesity, physical activity and the risk of pancreatic cancer in a large Japanese cohort
Lin, Y., Kikuchi, S., Tamakoshi, A., Yagyu, K., Obata, Y., Inaba, Y., Kurosawa, M., Kawamura, T., Motohashi, Y., Ishibashi, T., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22614 · Cited by 85
Lundgren, S., Kuitunen, S., Pietiläinen, K. H., Hurme, M., Kähönen, M. A. P., Männistö, S., Perola, M., Lehtimäki, T. J., Raitakari, O. T., Kaprio, J. A., et al. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13528 · Cited by 84
Is there a role for IGF ‐1 in the development of second primary cancers?
Shanmugalingam, T., Bosco, C., Ridley, A. J., & Hemelrijck, M. V. (2016) · Cancer Medicine · doi:10.1002/cam4.871 · Cited by 84
Hartge, P. A., Wang, S., Bracci, P. M., Devesa, S. S., & Holly, E. A. (2006) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195149616.003.0046 · Cited by 84
Söderberg, K. C., Kaprio, J. A., Verkasalo, P. K., Pukkala, ., Koskenvuo, M. J., Lundqvist, E., & Feychting, M. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.11.004 · Cited by 83
Troy, J. D., Hartge, P. A., Weissfeld, J. L., Oken, M. M., Colditz, G. A., Mechanic, L. E., & Morton, L. M. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq085 · Cited by 82
Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men
Larsson, S. C., Andersson, S., Johansson, J., & Wolk, A. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.07.012 · Cited by 81
Self-citationObesity is associated with worse oncological outcomes in patients treated with radical cystectomy
Chromecki, T. F., Cha, E. K., Fajković, H., Rink, M., Ehdaie, B., Svatek, R. S., Karakiewicz, P. I., Lotan, Y., Tilki, D., Bastian, P. J., et al. (2012) · British Journal of Urology · doi:10.1111/j.1464-410x.2012.11322.x · Cited by 81
Britton, J. A., Khan, A. E., Rohrmann, S., Becker, N., Linseisen, J., Nieters, A., Kaaks, R., Tjønneland, A. M., Halkjær, J., Severinsen, M. T., et al. (2008) · Haematologica · doi:10.3324/haematol.13078 · Cited by 81
Hsieh, Y., Shen, C., Huang, W., Chin, C., Kuo, Y.-H., Hsieh, M. C., Yu, H., Chang, T., Lin, T., Chiu, Y.-W., et al. (2014) · Journal of Biomedical Science · doi:10.1186/1423-0127-21-59 · Cited by 81
Body Mass Index, Height, and Risk of Lymphatic Malignancies: A Prospective Cohort Study
Pylypchuk, R. D., Schouten, L. J., Goldbohm, R. A., Schouten, H. C., & van den Brandt, P. A. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp123 · Cited by 81
Inoue, M., Sobue, T., & Tsugane, S. (2004) · Cancer Causes & Control · doi:10.1023/b:caco.0000036177.77953.47 · Cited by 81
Hepatocellular carcinoma: natural history, current management, and emerging tools
Haas-Kogan, D. A., & Tinkle, C. L. (2012) · Biologics · doi:10.2147/btt.s23907 · Cited by 80
Tan, A., Dang, Y., Chen, G., & Mo, Z. (2015) · PubMed Central · Cited by 80
Vanni, E., & Bugianesi, E. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.09.001 · Cited by 79
Fernberg, P., Odenbro, Å., Bellocco, R., Boffetta, P., Yudi Pawitan, Y., Zendehdel, K., & Adami, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0274 · Cited by 79
Epidemiologic and etiologic factors of pancreatic cancer
Lowenfels, A. B., & Maisonneuve, P. (2002) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(01)00003-x · Cited by 79
Minireview: Obesity and Breast Cancer: A Tale of Inflammation and Dysregulated Metabolism
Simpson, E. R., & Brown, K. A. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1011 · Cited by 78
Lee, J. K., So, K. A., Piyathilake, C. J., & Kim, M. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066555 · Cited by 77
Ohtani, N. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0457-1 · Cited by 76
Body Mass Index, Abnormal Glucose Metabolism, and Mortality from Hematopoietic Cancer
Chiu, B. C. ‐., Gapstur, S. M., Greenland, P., Wang, R., & Dyer, A. R. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0007 · Cited by 76
Holick, C. N., Giovannucci, E. L., Stampfer, M. J., & Michaud, D. S. (2006) · International Journal of Cancer · doi:10.1002/ijc.22142 · Cited by 75
Pan, S. Y., Mao, Y., & Ugnat, A. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi342 · Cited by 75
Waalkes, S., Merseburger, A. S., Kramer, M. W., Herrmann, T. R. W., Wegener, G., Rustemeier, J., Hofmann, R. W., Schrader, M. G., Kuczyk, M. A., & Schrader, A. J. (2010) · Cancer Causes & Control · doi:10.1007/s10552-010-9618-2 · Cited by 74
Kuper, H., Cramer, D. W., & Titus-Ernstoff, L. T. (2002) · Cancer Causes & Control · doi:10.1023/a:1015751105039 · Cited by 74
The role of resistin in colorectal cancer
Danese, E., Montagnana, M., Minicozzi, A. M., Bonafini, S., Ruzzenente, O., Gelati, M., Manzoni, G. D., Lippi, G., & Guidi, G. C. (2012) · Clinica Chimica Acta · doi:10.1016/j.cca.2012.01.019 · Cited by 72
Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me–Can)
Ulmer, H., Bjørge, T., Concin, H., Lukanova, A., Manjer, J., Hallmans, G., Borena, W., Häggström, C., Engeland, A., Almquist, M., et al. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.01.052 · Cited by 72
Anthropometrics, Physical Activity, Related Medical Conditions, and the Risk of Non-Hodgkin Lymphoma
Cerhan, J. R., Bernstein, L., Severson, R. K., Davis, S., Colt, J. S., Blair, A. E., & Hartge, P. A. (2005) · Cancer Causes & Control · doi:10.1007/s10552-005-0358-7 · Cited by 72
Obesity and Cancer: A Gut Microbial Connection
Ohtani, N., Yoshimoto, S., & Hara, E. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3501 · Cited by 71
Review article: steatosis, the metabolic syndrome and cancer
Bugianesi, E. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02594.x · Cited by 71
Body mass index in relation to ovarian cancer: A multi‐centre nested case‐control study
Lukanova, A., Toniolo, P. G., Lundin, E., Micheli, A., Akhmedkhanov, A., Muti, P. C., Zeleniuch‐Jacquotte, A., Biessy, C., Lenner, P., Krogh, V., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10374 · Cited by 71
Insulin Resistance and Other Metabolic Risk Factors in the Pathogenesis of Hepatocellular Carcinoma
Siddique, A., & Kowdley, K. V. (2011) · Clinics in Liver Disease · doi:10.1016/j.cld.2011.03.007 · Cited by 70
Body Mass Index and Risk of Malignant Lymphoma in Scandinavian Men and Women
Chang, E. T., Hjalgrim, H., Smedby, K. E. E., Åkerman, M., Tani, E. M., Johnsen, H. E., Glimelius, B., Adami, H., & Melbye, M. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji012 · Cited by 69
Self-citationAnthropometric Characteristics and Risk of Multiple Myeloma
Blair, C. K., Cerhan, J. R., Folsom, A. R., & Ross, J. A. (2005) · Epidemiology · doi:10.1097/01.ede.0000172135.61188.2d · Cited by 69
Wolter, S., Duprée, A., Miro, J., Schroeder, C., Jansen, M.-I., Wiesch, C. S. Z., Groth, S., Izbicki, J. R., Mann, O., & Busch, P. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2622-9 · Cited by 69
Kim, Y., Ejaz, A. M., Tayal, A., Spolverato, G., Bridges, J. F. P., Anders, R. A., & Pawlik, T. M. (2014) · Cancer · doi:10.1002/cncr.28843 · Cited by 68
Dar, K. K., Ali, S., Ejaz, M., Nasreen, S., Ashraf, N., Gillani, S. F., Shafi, N., Safeer, S., Khan, M. A., Andleeb, S., et al. (2019) · Brazilian Journal of Biology · doi:10.1590/1519-6984.186565 · Cited by 68
Diabetes mellitus and metformin in hepatocellular carcinoma
Fujita, K., Iwama, H., Miyoshi, H., Tani, J., Oura, K., Tadokoro, T., Sakamoto, T., Nomura, T., Morishita, A., Yoneyama, H., et al. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i27.6100 · Cited by 68
Trends in incidence rates for obesity-associated cancers in the US
Polednak, A. P. (2003) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2003.09.002 · Cited by 68
Obesity and esophageal cancer: GERD, Barrett´s esophagus, and molecular carcinogenic pathways
Schlottmann, F., Dreifuss, N. H., & Patti, M. G. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2020.1764348 · Cited by 67
The conserved NAD(H)-dependent corepressor CTBP-1 regulates Caenorhabditis elegans life span
Chen, S., Whetstine, J. R., Ghosh, S. K., Hanover, J. A., Gali, R. R., Grosu, P., & Shi, Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802674106 · Cited by 67
Interleukin-6-Related Genotypes, Body Mass Index, and Risk of Multiple Myeloma and Plasmacytoma
Cozen, W., Gebregziabher, M., Conti, D. V., Berg, D. J. V. D., Coetzee, G. A., Wang, S., Rothman, N., Bernstein, L., Hartge, P. A., Morhbacher, A., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0446 · Cited by 66
Non-viral factors contributing to hepatocellular carcinoma
Hamed, M. A. A., & Ali, S. A. (2013) · World Journal of Hepatology · doi:10.4254/wjh.v5.i6.311 · Cited by 66
Body Mass Index and Risk of Leukemia in Older Women
Ross, J. A., Parker, E. D., Blair, C. K., Cerhan, J. R., & Folsom, A. R. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.1810.13.11 · Cited by 66
Sinner, P. J., Schmitz, K. H., Anderson, K. E., & Folsom, A. R. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0036 · Cited by 66
Sjödahl, K., Jia, C., VATTEN, L. J., Nilsen, T. I. L., Hveem, K., & Lagergren, J. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0704 · Cited by 65
Bakar, D., & Mehrzad, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90965-5.00006-4 · Cited by 65
Ehdaie, B., Chromecki, T. F., Lee, R. K., Lotan, Y., Margulis, V., Karakiewicz, P. I., Novara, G., Raman, J. D., Ng, C. K., Lowrance, W. T., et al. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.03.031 · Cited by 64
Metadata
- Authors
- Wolk, A., Gridley, G., Svensson, M., Nyrén, O., McLaughlin, J. K., Fraumeni, J. F., & Adami, H.-O.
- Affiliations
- Karolinska Institutet (SE)
- National Cancer Institute (US)
- International Epidemiology Institute (US)
- Corresponding author
- Wolk, Alicja
- Venue
- Cancer Causes & Control
- Published
- 2001-01
- Volume
- 12
- Issue
- 1
- Pages
- 13-21
- ISSN
- 0957-5243 (ISSN-L)
- 1573-7225
- OpenAlex
- W1522687886
- Cited by
- 581
- References
- 77
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 6 · 2023: 8 · 2022: 14 · 2021: 9 · 2020: 21 · 2019: 19 · 2018: 19 · 2017: 13 · 2016: 23 · 2015: 29 · 2014: 33 · 2013: 40 · 2012: 44
- FWCI
- 7.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Cancer Causes & Control (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01cp085636-006008)
- National Cancer Institute (N01-CP-85636)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- obesity, cancer risk, cancer incidence, standardized incidence ratio, small intestine neoplasms, colon cancer, gallbladder cancer, pancreatic cancer, laryngeal cancer, bladder cancer, cervical cancer, endometrial cancer, ovarian cancer, brain cancer, Hodgkin's disease, non-Hodgkin lymphoma, breast cancer, prostate cancer
- MeSH terms
- Adolescent, Adult, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neoplasms, Obesity, Patient Discharge, Population Surveillance, Registries, Risk Factors, Sweden, Comorbidity, Incidence, Prevalence, Sex Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review